Our two DUXAP10-CRISPRi cell lines significantly reduced the rapid growth and metastatic behaviors characteristic of ATC, affecting proliferation, viability, clonogenicity, apoptosis, invasion, migration, tumorigenesis, and metastasis. Thus, DUXAP10 is a proposed prognostic marker and therapeutic target for ATC disease propagation and progression.
Our findings confirm the influence of CSC features in NB prognosis. The newly developed NB stemness-related four-gene signature prognostic signature could facilitate the prognostic prediction, and the identified hub genes may serve as promising targets for individualized treatments.
2 years ago
Journal • Machine learning
|
MYCN (MYCN Proto-Oncogene BHLH Transcription Factor) • DIRAS3 (DIRAS Family GTPase 3) • ERCC6 (Excision repair cross-complementation group 6) • DUXAP10 (Double Homeobox A Pseudogene 10)